Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 109

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Effect of indacaterol on exercise endurance and lung hyperinflation in COPD

O’Donnell, Denis E., Casaburi, Richard, Vincken, Walter, Puente-Maestu, Luis, Swales, James, Lawrence, David, Kramer, Benjamin·2011·Respiratory Medicine

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.rmed.2011.03.014

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 18

  1. O’Donnell, 1999, Spirometric correlates of improvement in exercise performance after anticholinergic therapy in COPD, Am J Respir Crit Care Med, 160, 542
  2. Esteban, 2010, Impact of changes in physical activity on health-related quality of life among patients with chronic obstructive pulmonary disease, Eur Respir J, 36, 292
  3. Neder, 2007, Effects of formoterol on exercise tolerance in severely disabled patients with COPD, Respir Med, 101, 2056
  4. Maltais, 2005, Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD, Chest, 128, 1168
  5. Cazzola, 2005, Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease, Expert Opin Investig Drugs, 14, 775
  6. Dahl, 2010, Efficacy of a new once-daily long-acting inhaled β2-agonist indacaterol versus twice-daily formoterol in COPD, Thorax, 65, 473
  7. Donohue, 2010, Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium, Am J Respir Crit Care Med, 182, 155
  8. Feldman, 2010, Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study, BMC Pulm Med, 10, 11
  9. Quanjer, 1993, Lung volumes and forced ventilatory flows, Eur Respir J, 6, 5
  10. 2003, ATS/ACCP statement on cardiopulmonary exercise testing, Am J Respir Crit Care Med, 167, 211
  11. O’Donnell, 2004, Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD, Eur Respir J, 23, 832
  12. Puente-Maestu, 2009, Clinical relevance of constant power exercise duration changes in COPD, Eur Respir J, 34, 340
  13. O’Donnell, 2009, Reliability of ventilatory parameters during cycle ergometry in multicenter trials in COPD, Eur Respir J, 34, 866
  14. Oga, 2007, Longitudinal deteriorations in patient reported outcomes in patients with COPD, Respir Med, 101, 146
  15. Kesten, 2008, Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients, Int J COPD, 3, 127
  16. Pasqua, 2010, Combining triple therapy and pulmonary rehabilitation in patients with advanced COPD: a pilot study, Resp Med, 104, 412
  17. Vogiatzis, 2008, Chest wall volume regulation during exercise in COPD patients with GOLD stages II to IV, Eur Respir J, 32, 42
  18. Kornmann, 2011, Once daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison, Eur Resp J, 37, 273

Cited by

Metadata

Authors
O’Donnell, D. E., Casaburi, R., Vincken, W., Puente-Maestu, L., Swales, J., Lawrence, D., & Kramer, B.
Venue
Respiratory Medicine
Publisher
Elsevier BV
Published
2011-07
Volume
105
Issue
7
Pages
1030-1036
ISSN
0954-6111
Cited by
109
References
4
Language
en
Funders
Novartis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.